Jiang Xinxin Medtec Co's Total Assets for the quarter that ended in Mar. 2025 was ¥2,227 Mil.
During the past 12 months, Jiang Xinxin Medtec Co's average Total Assets Growth Rate was 2.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 14.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 13.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 17.90% per year.
During the past 13 years, Jiang Xinxin Medtec Co's highest 3-Year average Total Assets Growth Rate was 26.50%. The lowest was 12.00%. And the median was 21.30%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Jiang Xinxin Medtec Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiang Xinxin Medtec Co (SZSE:300453) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Jiang Xinxin Medtec Co's Asset Turnover for the quarter that ended in Mar. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Jiang Xinxin Medtec Co Total Assets Related Terms
Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300453 has been successfully added to your 